MOLECULAR MECHANISMS OF RESISTANCE OF ENDOMETRIAL HYPERPLASIA TO PROGESTAGEN THERAPY

D. A. Khaskhachykh, В. О. Потапов, І. Гарагуля
In: Grail of Science · 2023 · pp. 433–439 · doi:10.36074/grail-of-science.17.03.2023.076 · W4362664326
article OA: hybrid CC0
🔓 Open OA copy View on OpenAlex View at publisher

Abstract

The problem of resistance of atypical endometrial hyperplasia (AGE) to traditionally accepted, pathogenetically justified therapy with various types of progestins remains unsolved today. In approximately 17-20% of cases, there is a recurrence or even progression to atypical hyperplasia of the endometrium, which requires the use of surgical methods of treatment. The aim of the study was to review the literature sources to clarify the reasons for the resistance of endometrial hyperplasia without atypia to hormone therapy with different types of progestins in women with different types of estrogen and progesterone receptor expression in combination with the expression of the intercellular adhesion molecules E-cadherin and β-catenin.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (1)

References (19)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK